IPP Bureau
Siegfried locks in CHF 200m bond deal as investors bet big on pharma outsourcing boom
By IPP Bureau - May 27, 2026
The bonds, due June 15, 2030, were placed with Swiss investors under the joint lead of UBS and Zürcher Kantonalbank
Eli lilly goes all-in on vaccines with $3b+ triple acquisition push into infectious disease prevention
By IPP Bureau - May 27, 2026
Lilly will acquire Curevo in a deal worth up to $1.5 billion in cash, including upfront and milestone-based payments.
Align Tech to open $200M manufacturing facility in Hyderabad aiming 300+ jobs
By IPP Bureau - May 27, 2026
The new facility marks Align’s first manufacturing presence in India and its fourth globally
Sun's cancer drug shines delivering 50% response rate with long-lasting tumor control
By IPP Bureau - May 27, 2026
These data support clinically meaningful efficacy within this patient population. We observed a high rate of complete responses in patients with laCSCC
President of India confers Padma Shri Award on Dr. P. Vijay Anand Reddy
By IPP Bureau - May 26, 2026
The director of Apollo Cancer Centres in Hyderabad and founder of CURE Foundation honored for his contributions to cancer awareness and treatment
Dr. Ramesh Juneja joins Alembic Pharmaceuticals as Head – India Business
By IPP Bureau - May 26, 2026
With over three decades of extensive industry experience, Ramesh Juneja brings a strong track record of building and scaling large businesses
Amgen appoints Madhur Sarin as Director – AI & Data Science COE
By IPP Bureau - May 26, 2026
Sarin will focus on advancing scalable AI-driven platforms and strengthening the company’s global data science capabilities across healthcare and enterprise technology domains
Cornerstone Robotics secures EU CE mark and Singapore HSA approval for Sentire Surgical System
By IPP Bureau - May 26, 2026
Dual regulatory clearances for Sentire(R) Endoscopic surgical system strengthen the company’s expansion across Europe and Asia-Pacific in minimally invasive robotic surgery
Lilly posts strong early clinical results for one-shot gene-editing cholesterol therapy
By IPP Bureau - May 26, 2026
A one-shot gene-editing cholesterol therapy could soon be a reality
Fredun FY26 profit jumps 60% as revenue hits Rs. 639 Cr
By IPP Bureau - May 26, 2026
International Nurses Day 2026: WHO highlights global nursing gaps despite workforce growth
By IPP Bureau - May 26, 2026
Fresh data from the State of the World’s Nursing 2025 report shows the global nursing workforce has expanded from 27.9 million in 2018 to 29.8 million in 2023
China greenlights Boehringer Ingelheim’s HERNEXEOS for aggressive lung cancer
By IPP Bureau - May 26, 2026
The decision clears the drug as a monotherapy for adults with unresectable, locally advanced or metastatic non-small cell lung cancer
EMA backs conditional EU nod for Vijoice in rare life-threatening overgrowth disorder PROS
By IPP Bureau - May 26, 2026
The company is expected to conduct further studies to confirm the long-term efficacy and safety of Vijoice in both adult and paediatric patients
Genethon and Ampersand team up to engineer next-gen gene therapy vectors with precision
By IPP Bureau - May 26, 2026
AAV vectors are widely used in gene therapy for their strong therapeutic potential
Merck’s KEYTRUDA combo wins key EU backing for bladder cancer treatment
By IPP Bureau - May 25, 2026
The decision now moves to the European Commission, with a final ruling expected by the third quarter of 2026
